Physician profile
Sandra Cayler
NPI 1003466921
$2,117.15
in general payments reported to CMS, 2019-2025
15 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $650 · 2022: $793 · 2023: $104 · 2024: $205 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $415.98 | 2021-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $394.46 | 2021-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $304.24 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $268.34 | 2021-2025 | Spravato, Invega Sustenna |
| Alkermes, INC. | $247.44 | 2021-2023 | Aristada, Lybalvi |
| Lundbeck LLC | $187.04 | 2021-2025 | Rexulti, Brintellix |
| Teva Pharmaceuticals USA, INC. | $60.83 | 2022-2023 | Austedo |
| Almatica Pharma LLC | $51.65 | 2021-2025 | Loreev Xr |
| Axsome Therapeutics, INC. | $49.33 | 2022-2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $37.35 | 2025 | Trintellix |
| Abbvie INC. | $25.31 | 2024 | |
| Idorsia Pharmaceuticals US INC | $21.51 | 2025 | Quviviq |
| Neos Therapeutics, LP | $20.00 | 2025 | Adzenys Xr-Odt |
| Tris Pharma INC | $19.53 | 2025 | Dyanavel Xr |
| Sunovion Pharmaceuticals INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Cayler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.